Telemedicine is increasingly playing a vital role in European health systems, offering great potential for
improving healthcare access and outcomes. Funded between September 2022 and December 2024, the
Joint Action ‘Strengthening eHealth including telemedicine and remote monitoring for health care systems
for CANcer prevention and care’ (eCAN JA) provided evidence-base for person-centred implementation
of telemedicine services among cancer patients in the European Union (EU). Through a mixed-method
approach, this foresight study gathered insights from key decision-makers in 14 EU Member States and
eight cancer patient associations via two surveys and a joint workshop, conducted within the Sustainability
Work Package (WP4) of the eCAN JA. Our results show that EU Member States and cancer patients view
telemedicine as a useful and complementary tool, however, not as a replacement for in-person services for
cancer care. The policy recommendations from our study can be summarised as follows: (i) develop legal
frameworks to complement in-person care with telemedicine; (ii) improve digital literacy and information
technology infrastructure while ensuring privacy and health equity; and (iii) engage patients in the co
design of telemedicine services. Implementing these recommendations will enhance the integration of
telemedicine into cancer care in Europe.